RESISTÊNCIA À INSULINA E SÍNDROME METABÓLICA EM PACIENTES COM TRANSTORNO DO HUMOR BIPOLAR

[1]  R. Post,et al.  Allostatic load in bipolar disorder: Implications for pathophysiology and treatment , 2008, Neuroscience & Biobehavioral Reviews.

[2]  D. Kupfer,et al.  Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. , 2008, Journal of psychiatric research.

[3]  Y. Hung,et al.  Identifying Subjects with Insulin Resistance by Using the Modified Criteria of Metabolic Syndrome , 2008, Journal of Korean medical science.

[4]  P. Keck,et al.  Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  J. Farmer,et al.  Role of insulin signaling in maintaining energy homeostasis. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  H. Kenna,et al.  P0146 - Insulin resistance and hyperlipidemia in women with bipolar disorder , 2008, European Psychiatry.

[7]  M. De Hert,et al.  Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. , 2008, Bipolar disorders.

[8]  M. Frye,et al.  Modal subcomponents of metabolic syndrome in patients with bipolar disorder. , 2008, Journal of affective disorders.

[9]  J. Bobes,et al.  The prevalence of metabolic syndrome in patients with bipolar disorder. , 2008, Journal of affective disorders.

[10]  E. D. Oliveira,et al.  Síndrome Metabólica, seus fenótipos e resistência à insulina pelo HOMA-RI , 2007 .

[11]  Paulo José Ribeiro Teixeira,et al.  The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. , 2007, Revista brasileira de psiquiatria.

[12]  Y. Hung,et al.  Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder , 2007, Clinical endocrinology.

[13]  D. Leroith,et al.  Insulin resistance as the underlying cause for the metabolic syndrome. , 2007, The Medical clinics of North America.

[14]  S. Kennedy,et al.  Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? , 2007, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[15]  A. Arteaga,et al.  Association between proinsulin, insulin, proinsulin/insulin ratio, and insulin resistance status with the metabolic syndrome. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[16]  G. MacQueen,et al.  Cognitive dysfunction associated with metabolic syndrome , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[17]  A. Kilbourne,et al.  Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. , 2007, Psychosomatics.

[18]  K. Rajagopalan,et al.  Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims database. , 2007, Primary care companion to the Journal of clinical psychiatry.

[19]  S. Kennedy,et al.  Medical comorbidity in bipolar disorder: reprioritizing unmet needs , 2007, Current opinion in psychiatry.

[20]  I. Ferrier,et al.  Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. , 2007, The British journal of psychiatry : the journal of mental science.

[21]  J. Yudkin.  Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology , 2007, Diabetologia.

[22]  Anja Vaskinn,et al.  The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. , 2007, The Journal of clinical psychiatry.

[23]  P. Mortensen,et al.  Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. , 2007, The Journal of clinical psychiatry.

[24]  D. Allison,et al.  Waist Circumference and Cardiometabolic Risk , 2007, Diabetes Care.

[25]  M. Jakovljevič,et al.  Mental disorders and metabolic syndrome: a fatamorgana or warning reality? , 2007, Psychiatria Danubina.

[26]  G. Marchesini,et al.  Correspondence Between the International Diabetes Federation Criteria for Metabolic Syndrome and Insulin Resistance in a Cohort of Italian Nondiabetic Caucasians , 2007, Diabetes Care.

[27]  B. Balkau,et al.  Consequences of Change in Waist Circumference on Cardiometabolic Risk Factors Over 9 Years , 2007, Diabetes Care.

[28]  S. Selek,et al.  Atypical antipsychotics related metabolic syndrome in bipolar patients. , 2007, Journal of affective disorders.

[29]  J. Calabrese,et al.  Overweight and obesity in bipolar disorders. , 2006, Journal of psychiatric research.

[30]  A. Fagiolini,et al.  Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. , 2006, The Journal of clinical psychiatry.

[31]  G. Reaven,et al.  The metabolic syndrome: is this diagnosis necessary? , 2006, The American journal of clinical nutrition.

[32]  D. Kupfer,et al.  Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. , 2006, The Journal of clinical psychiatry.

[33]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[34]  B. Geloneze,et al.  The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. , 2006, Diabetes research and clinical practice.

[35]  C. Correll,et al.  Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. , 2006, The Journal of clinical psychiatry.

[36]  Bruce D. Johnson,et al.  Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance. , 2006, Diabetes care.

[37]  C. Kuo,et al.  A retrospective analysis of risk and protective factors for natural death in bipolar disorder. , 2005, The Journal of clinical psychiatry.

[38]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[39]  G. Reaven.  Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. , 2005, Panminerva medica.

[40]  J. Calabrese,et al.  Use of health care services among persons who screen positive for bipolar disorder. , 2005, Psychiatric services.

[41]  D. Kupfer,et al.  Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. , 2005, Bipolar disorders.

[42]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[43]  Anoop Misra,et al.  Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. , 2005, Nutrition.

[44]  M. Alda,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. , 2005, Bipolar disorders.

[45]  T. Suppes,et al.  Reproductive function and risk for PCOS in women treated for bipolar disorder. , 2005, Bipolar disorders.

[46]  David J Kupfer,et al.  The increasing medical burden in bipolar disorder. , 2005, JAMA.

[47]  R. Bergman,et al.  Abdominal obesity predicts declining insulin sensitivity in non‐obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS) , 2005, Diabetes, obesity & metabolism.

[48]  A. Kilbourne,et al.  Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. , 2005, Journal of affective disorders.

[49]  Peter Arner,et al.  Use of waist circumference to predict insulin resistance: retrospective study , 2005, BMJ : British Medical Journal.

[50]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[51]  S. Kennedy,et al.  Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[52]  K.,et al.  Psychiatric and Medical Comorbidities of Bipolar Disorder , 2005, Psychosomatic medicine.

[53]  I. Heuser,et al.  Lipid Metabolism and Insulin Resistance in Depressed Patients: Significance of Weight, Hypercortisolism, and Antidepressant Treatment , 2004 .

[54]  Joseph Conigliaro,et al.  Burden of general medical conditions among individuals with bipolar disorder. , 2004, Bipolar disorders.

[55]  G. Reaven.  The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. , 2004, Endocrinology and metabolism clinics of North America.

[56]  C. Lamendola,et al.  Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. , 2004, Diabetes.

[57]  D. Kupfer,et al.  Suicide attempts and ideation in patients with bipolar I disorder. , 2004, The Journal of clinical psychiatry.

[58]  P. Keck,et al.  Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. , 2003, The Journal of clinical psychiatry.

[59]  B. S. Duman,et al.  Effect of Abdominal Obesity on Insulin Resistance and the Components of the Metabolic Syndrome: Evidence Supporting Obesity as the Central Feature , 2003, Obesity surgery.

[60]  J. Real,et al.  Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. , 2003, European journal of internal medicine.

[61]  E. Yano,et al.  Use of general medical services by VA patients with psychiatric disorders. , 2002, Psychiatric services.

[62]  I. Heuser,et al.  Hypercortisolemic Depression Is Associated With Increased Intra-Abdominal Fat , 2002, Psychosomatic medicine.

[63]  T. Suppes,et al.  Correlates of overweight and obesity in 644 patients with bipolar disorder. , 2002, The Journal of clinical psychiatry.

[64]  S. Lemieux.  Contribution of visceral obesity to the insulin resistance syndrome. , 2001, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[65]  L. Altshuler,et al.  Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. , 2000, The Journal of clinical psychiatry.

[66]  E. Vieta,et al.  Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients , 1999, Psychological Medicine.

[67]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[68]  J. Vallejo,et al.  Prediction of depressive relapse in remitted bipolar patients using corticotrophin‐releasing hormone challenge test , 1997, Acta psychiatrica Scandinavica.

[69]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[70]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[71]  P. Keck,et al.  Managing metabolic abnormalities in the psychiatrically ill : a clinical guide for psychiatrists , 2007 .

[72]  J. Newcomer,et al.  Medical risk in patients with bipolar disorder and schizophrenia. , 2006, The Journal of clinical psychiatry.

[73]  S. Beaulieu,et al.  The metabolic syndrome during atypical antipsychotic drug treatment: mechanisms and management. , 2004, Metabolic syndrome and related disorders.

[74]  D. Kupfer,et al.  Obesity as a correlate of outcome in patients with bipolar I disorder. , 2003, The American journal of psychiatry.